GPC3 and neoplasm: LNP-engineered Siglec-GΔITIMs-expressing GPC3-specific CAR-Ms present augmented HCC-specific engulfment of macrophages, subsequently stimulating an adaptive anti-tumour immune response and preventing tumour growth in an orthotopic HCC mouse model.